| ALA | aminolevulinic acid |
| BMP-2 | bone morphogenetic proteins 2 |
| BMP-7 | bone morphogenetic proteins 7 |
| BPs | bisphosphonates |
| DMLS | direct metal laser sintering |
| DSD | shock debridement technology |
| FGF-2 | fibroblast growth factor 2 |
| hMSC | human mesenchymal stem cells |
| IAJ | implant–abutment junction |
| IGF-1 | insulin-like growth factor 1 |
| IMDDS | implant-mediated drug delivery system |
| nZnO | nano-zinc oxide |
| mod-SLA | modified sandblasted acid-etched surface |
| MTT | (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| PIGF-2 | placenta growth factor |
| PLGA | poly-lactic glycolic acid |
| PS | platform switching or platform shifting |
| PTH | parathyroid hormone |
| rhBMP-2 | recombinant human bone morphogenetic protein |
| standard SLA surface | modification-regarded rinsing implant after etching in nitrous protection and storing in isotonic NaCl solution |
| TGF-β | transforming growth factor β |
| VEGF | vascular endothelial growth factor |